Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

astrazeneca_plaque

AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma

August 6, 2020 Research and Development AstraZeneca, Fasenra, asthma

AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …
News
morris

Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer

August 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …
Appointment
nice_new_london_office_internal_3_web

NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns

August 5, 2020 Research and Development, Sales and Marketing Ledaga, NICE, lymphoma

NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …
News
800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020 Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …
News

EMA expands label for UCB’s Cimzia in axial spondyloarthritis

August 5, 2020 Research and Development, Sales and Marketing Cimzia, EMA, Europe

The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020 Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …
News
coca-cola_bottles_for_thai_market_1

Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis

August 5, 2020 Research and Development, Sales and Marketing Coca-Cola, Coke

Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …
News
chrissy

Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
Appointment
enoch_kariuki

VelosBio reveals new Chief Financial Officer

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
Appointment
kymriah

Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma

August 4, 2020 Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy

Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …
News
1

CAR T cell therapy is revolutionising cancer treatment, but at what cost?

August 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
Feature
shutterstock_138095450

US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate

July 31, 2020 Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …
News
heart-2372134_640

Lilly and Boehringer’s Jardiance reduces hospitalisation and CV death risk from heart failure at Phase 3

July 30, 2020 Research and Development Boehringer, Eli Lilly, jardiance, pharma

Boehringer Ingelheim and Eli Lilly have announced strong Phase 3 news on their sodium-glucose co-transporter-2 (SGLT2) inhibitor Jardiance (empagliflozin) in …
News

Sanofi’s nirsevimab nails study goals for prevention of respiratory syncytial virus in infants

July 30, 2020 Research and Development Sanofi, nirsevimab, pharma

Sanofi’s nirsevimab met its goals in a Phase 2b study, the company has revealed, investigating its efficacy in the prevention …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026